{"id":842123,"title":"Mammalian cell culture-based influenza vaccines: National Advisory Committee on Immunization Supplemental Statement, CCDR 46(10) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T16:28:54.107000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/national-advisory-committee-immunization-supplemental-statement.html","snippet":"National Advisory Committee on Immunization Supplemental Statement Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 46–10: Laboratory Biosafety Date published: October 1, 2020 ISSN: 1481-8531 Subscribe to CCDR Submit your manuscript…","rawSnapshotUrl":"/api/snapshots/raw/842123","browseUrl":"https://replay.healtharchive.ca/job-7/20260303162854/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/national-advisory-committee-immunization-supplemental-statement.html#ha_snapshot=842123","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}